Application 219454
- Type
- ANDA
- Sponsor
- TRIS PHARMA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GANIRELIX ACETATE | GANIRELIX ACETATE | INJECTABLE;INJECTION | 250MCG/0.5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219454-001 | GANIRELIX ACETATE | GANIRELIX ACETATE | 250MCG/0.5ML | INJECTABLE / INJECTION | 2025-06-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219454-001 | GANIRELIX ACETATE | 250MCG/0.5ML | INJECTABLE / INJECTION | 2025-06-27 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A219454-001 | GANIRELIX ACETATE | 250MCG/0.5ML | INJECTABLE / INJECTION | 2025-06-27 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A219454-001 | GANIRELIX ACETATE | 250MCG/0.5ML | INJECTABLE / INJECTION | AP | 2025-06-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219454-001 | GANIRELIX ACETATE | 250MCG/0.5ML | INJECTABLE / INJECTION | AP | 2025-06-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A219454-001 | GANIRELIX ACETATE | 250MCG/0.5ML | INJECTABLE / INJECTION | AP | 2025-06-27 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219454-001 | GANIRELIX ACETATE | 250MCG/0.5ML | INJECTABLE / INJECTION | 2025-06-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219454-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219454-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A219454-001 | AP | 1 | 6a471c1ec25d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ganirelix Acetate | GANIRELIX ACETATE | Mullan Pharmaceutical Inc. | 420ce739-2756-4fb4-8a4e-5fab501ab973 | 2026-05-11 | Warnings, Adverse reactions | Ganirelix Acetate GANIRELIX ACETATE |
| Ganirelix Acetate | GANIRELIX ACETATE | Xiromed LLC | 37a8e041-9751-665a-1965-765f7ff21922 | 2026-03-18 | Warnings, Adverse reactions | Ganirelix Acetate GANIRELIX ACETATE |
| Ganirelix Acetate | GANIRELIX ACETATE | Organon LLC | 32fb74ff-993a-49fe-8943-e029372b863e | 2025-11-13 | Warnings, Adverse reactions | Ganirelix Acetate GANIRELIX ACETATE |
| Ganirelix Acetate | GANIRELIX ACETATE | Lupin Pharmaceuticals, Inc. | e50888ef-5e66-4b15-bdc3-2f6794f09246 | 2025-09-03 | Warnings, Adverse reactions | Ganirelix Acetate GANIRELIX ACETATE |
| Ganirelix Acetate | GANIRELIX ACETATE | Qilu Pharmaceutical Co., Ltd. | 440f6d67-f02e-4407-8830-39c394e25e5d | 2025-07-15 | Warnings, Adverse reactions | Ganirelix Acetate GANIRELIX ACETATE |
| Ganirelix Acetate | GANIRELIX ACETATE | Meitheal Pharmaceuticals Inc. | 1f067dfb-f9c7-4020-ab7b-da2ba695ab32 | 2025-02-20 | Warnings, Adverse reactions | Ganirelix Acetate GANIRELIX ACETATE |
| Fyremadel | GANIRELIX ACETATE | Ferring Pharmaceuticals Inc. | 5f0908b5-3551-47fd-95f7-3669b0dff7f1 | 2025-01-06 | Warnings, Adverse reactions | GANIRELIX ACETATE |
| Ganirelix Acetate | GANIRELIX ACETATE | Fresenius Kabi USA, LLC | c23ca7b2-7350-4f07-8adf-046bffb47842 | 2024-05-22 | Warnings, Adverse reactions | Ganirelix Acetate GANIRELIX ACETATE |
| GANIRELIX ACETATE | GANIRELIX ACETATE | Gland Pharma Limited | cad7c09c-234b-4e73-b460-a1b1f7adc28d | 2023-11-29 | Warnings, Adverse reactions | GANIRELIX ACETATE GANIRELIX ACETATE |
| Ganirelix Acetate | GANIRELIX ACETATE | Amphastar Pharmaceuticals, Inc. | 9c286f64-8039-44ec-8fdd-d1a2f52b4c3c | 2022-04-19 | Warnings, Adverse reactions | Ganirelix Acetate GANIRELIX ACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.